Inclisiran
Indication
For treating primary hypercholesterolaemia or mixed dyslipidaemia (NICE TA733)
Please refer to the LSCMMG inclisiran position statement for further information on use within Lancashire and South Cumbria.
Brand:
Nice TA:
733
Commissioning responsibility:
CCG
PbR excluded:
No
Background
To be used in accordance with the 'Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD'.
Please refer to the LSCMMG inclisiran position statement for further information on use within Lancashire and South Cumbria.
Included in NHS England HCD list to facilitate prescribing in secondary care until primary care prescribing is established.
Recommendation
LSCMMG Recommendation:
Green (Restricted)
Reason for decision:
Suitable for initiation in primary care in line with restrictions